following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
.
.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
https://drbryanpwalsh.com/Loran-brother-of-Rudeen-from-Montreal?Hagginson=245